| 中药上市后证候临床再评价模式探索 |
| |
| 引用本文： | 何伟,谢雁鸣. 中药上市后证候临床再评价模式探索[J]. 中医杂志, 2012, 53(4): 297-298,313 |
| |
| 作者姓名： | 何伟 谢雁鸣 |
| |
| 作者单位： | 1. 中国中医科学院博士后流动站,北京市,100700
2. 中国中医科学院中医临床基础医学研究所 |
| |
| 基金项目： | 中国博士后科学基金资助项目(20100470512) |
| |
| 摘 要： | 中药上市后证候临床再评价模式是需要慎重思考的顶层设计内容,应明确其分类、适用条件及优缺点等重点内容.证候临床再评价模式大致分为病证结合再评价模式、证候再评价模式及西医病症再评价模式,其中以病证结合再评价模式最为常用,后两者应用范围有限.在中药上市后证候临床再评价中,应根据再评价目的及设计方法等要求,选取适宜的证候临床再评价模式.
|
| 关 键 词： | 中药 上市后临床再评价 证候 |
Exploration on the Mode of Postmarketing Evaluation of Chinese Medicine on TCM Syndromes |
| |
| HE Wei , XIE Yanming. Exploration on the Mode of Postmarketing Evaluation of Chinese Medicine on TCM Syndromes[J]. Journal of Traditional Chinese Medicine, 2012, 53(4): 297-298,313 |
| |
| Authors: | HE Wei XIE Yanming |
| |
| Affiliation: | 1.Postdoctoral Research Station,China Academy of Chinese Medical Sciences,Be ijing 100700;2.Institute of Preclinical Medicine,China Academy of Chinese Med ical Sciences) |
| |
| Abstract: | The mode of postmarketing evaluation of Chinese medicine on TCM syndromes is the top design content which requires a careful thi nking.In the design,the key contents should be confirmed on the classification,application conditions,and advantages and disadvantages of the mode.The mode of TCM syndromes evaluation include the disease-syndrome in combina tion re-evaluation mode,syndrome re-evaluation mode,and disease re-evaluati on mode,of which,the first one is most commonly used,and the application of the other two is not common.In the postmarketing evaluation,the app ropriate clinical re-evaluation mode of TCM syndromes should be selected on the basis of purpose and design method. |
| |
| Keywords: | Chinese medicines postmarketing evaluation of Chinese medicines TCM syndromes |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
